logo
logo
Sign in

Intragastric Balloon Market is Estimated To Witness High Growth

avatar
sachin sadgir
Intragastric Balloon Market is Estimated To Witness High Growth

The global Intragastric Balloon Market is estimated to be valued at US$ 372.6 Million In 2023 and is expected to exhibit a CAGR of 9.6% over the forecast period 2023 - 2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:

Intragastric balloons are nonsurgical devices that aid in weight loss by occupying space in the stomach and creating a feeling of fullness. Intragastric balloons are effective, safe and minimally invasive for weight reduction and management of obesity or overweight conditions.

Market key trends:

One of the key trends in the intragastric balloon market is the rising preference for nonsurgical and minimally invasive weight loss procedures. With growing obesity worldwide, demand for effective yet less invasive weight management solutions is increasing. Intragastric balloons offer a safe and reversible option for weight loss without requiring surgery. They help in losing 10-15% of total body weight within 6 months. This is driving the uptake of intragastric balloons over high-risk bariatric surgeries.

Segment Analysis

The global intragastric balloon market is segmented by product, end use and filling material. By product, single intragastric balloons dominate the market due to advantages such as easy implantation process and removal. By end use, hospitals account for the largest share as most bariatric procedures are performed in hospitals. By filling material, saline-filled intragastric balloons hold the major market share owing to their low cost.

Key Takeaways

The global Intragastric Balloon Market size is expected to reach US$ 372.6 Million By 2023, expanding at a CAGR of 9.6% during the forecast period. The market is predicted to witness high growth due to increasing obesity prevalence worldwide mainly driven by sedentary lifestyle and unhealthy dietary habits.

Regional analysis

The US dominates the global intragastric balloon market and is expected to continue its lead during the forecast period. This can be attributed to rising obesity rates and availability of advanced intragastric balloon devices in the country. Europe is the second largest regional market backed by growing obese population and supportive government initiatives to address obesity.

Key players

Key players operating in the intragastric balloon market are Allergan (Acquired by Abbott), Apollo Endosurgery, Reshape Medical, Helioscopie Medical, Spatz FGIA, Endalis, Districlass Medical, Lexal, Medicone, Obalon Therapeutics, Silimed, Medsil, ReShape Lifesciences, EndoArt, MedSil, Silimed, Medsil, MetaCure, Semmle. Allergan (Acquired by Abbott) holds the major market share owing to its diversified portfolio of intragastric balloons and strong geographic presence worldwide.

Read More : https://www.rapidwebwire.com/intragastric-balloon-market-connected-with-allergan-acquired-by-abbott-driver-outline/

collect
0
avatar
sachin sadgir
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more